Advanced Radioactive Iodine Refractory-Differentiated Thyroid Cancer: Current Management Perspectives Sarimar Agosto Salgado, MD Moffitt Cancer…
Advanced Radioactive Iodine Refractory-Differentiated Thyroid Cancer: Current Management Perspectives Sarimar Agosto Salgado, MD Moffitt Cancer…
TERT promoter mutations in thyroid cancers Iñigo Landa, PhD Brigham and Women’s Hospital & Harvard…
Medullary Thyroid Cancer Danica M. Vodopivec, MD The University of Texas MD Anderson Cancer Center…
Patient’s Preferences Around Available Treatment Options for Thyroid Cancer Sara Ahmadi, MD, ECNU Brigham and…
Pediatric Thyroid Cancer, not a rare entity Siobhan T. Pittock, MD Mayo Clinic Rochester, MN…
An update on the management of Familial Non-Medullary Thyroid Cancer (FNMTC) Samira Mercedes Sadowski, MD…
Papillary Thyroid Cancer: Is Surgery Always Necessary? Trisha D. Cubb, MD Weill Cornell Medical College…
Thyroid Journal Program Thyroid®, Clinical Thyroidology®, and VideoEndocrinology™ Latest Impact Factor: 5.309 Special Collection: Virtual Review…
New Rochelle, NY, March 17, 2021—New guidelines for the diagnosis, evaluation, and treatment of anaplastic…
From Clinical Thyroidology® for the Public: As more patients are receiving organ transplants, it is…